Literature DB >> 18504019

SRP and Sec pathway leader peptides for antibody phage display and antibody fragment production in E. coli.

Holger Thie1, Thomas Schirrmann, Matthias Paschke, Stefan Dübel, Michael Hust.   

Abstract

Antibody phage display is a key technology for the generation of recombinant (human) antibodies for research, diagnostics and therapy. Most antibody fragments can only be folded correctly in the oxidizing environment of the periplasm of Escherichia coli. A multitude of leader peptides has been used for secretion of antibody::pIII fusion proteins into the periplasm, but a systematic study of their impact on the performance of antibody phage display systems has not been reported so far. In this work we have analysed the influence of various leader peptides on antibody phage display efficiency and production yields of soluble antibody fragments. Four leader peptides using the Sec pathway (PelB, OmpA, PhoA and pIII) and three using the SRP pathway (DsbA, TorT and TolB) were compared. Both pathways are compatible with antibody phage display and the production of soluble antibody fragments. The applicability of the SRP pathway to antibody phage display and the production of functional scFvs is shown here for the first time.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18504019     DOI: 10.1016/j.nbt.2008.01.001

Source DB:  PubMed          Journal:  N Biotechnol        ISSN: 1871-6784            Impact factor:   5.079


  22 in total

1.  Expression of high-affinity human antibody fragments in bacteria.

Authors:  Romain Rouet; David Lowe; Kip Dudgeon; Brendan Roome; Peter Schofield; David Langley; John Andrews; Peter Whitfeld; Lutz Jermutus; Daniel Christ
Journal:  Nat Protoc       Date:  2012-02-02       Impact factor: 13.491

2.  Engineering anti-vascular endothelial growth factor single chain disulfide-stabilized antibody variable fragments (sc-dsFv) with phage-displayed sc-dsFv libraries.

Authors:  Yi-Jen Huang; Ing-Chien Chen; Chung-Ming Yu; Yu-Ching Lee; Hung-Ju Hsu; Anna Tung Ching Ching; Hung-Ju Chang; An-Suei Yang
Journal:  J Biol Chem       Date:  2010-01-12       Impact factor: 5.157

Review 3.  Bacteriophage vehicles for phage display: biology, mechanism, and application.

Authors:  Walead Ebrahimizadeh; Masoumeh Rajabibazl
Journal:  Curr Microbiol       Date:  2014-03-18       Impact factor: 2.188

4.  Directed evolution of efficient secretion in the SRP-dependent export of TolB.

Authors:  Yaramah M Zalucki; William M Shafer; Michael P Jennings
Journal:  Biochim Biophys Acta       Date:  2011-06-16

5.  A secretory system for bacterial production of high-profile protein targets.

Authors:  Alexander Kotzsch; Erik Vernet; Martin Hammarström; Jens Berthelsen; Johan Weigelt; Susanne Gräslund; Michael Sundström
Journal:  Protein Sci       Date:  2011-03       Impact factor: 6.725

6.  An improved single-chain Fab platform for efficient display and recombinant expression.

Authors:  James T Koerber; Michael J Hornsby; James A Wells
Journal:  J Mol Biol       Date:  2014-12-03       Impact factor: 5.469

7.  Extracellular location of Thermobifida fusca cutinase expressed in Escherichia coli BL21(DE3) without mediation of a signal peptide.

Authors:  Lingqia Su; Ronald W Woodard; Jian Chen; Jing Wu
Journal:  Appl Environ Microbiol       Date:  2013-04-19       Impact factor: 4.792

8.  A novel heavy domain antibody library with functionally optimized complementarity determining regions.

Authors:  Ole Aalund Mandrup; Niels Anton Friis; Simon Lykkemark; Jesper Just; Peter Kristensen
Journal:  PLoS One       Date:  2013-10-08       Impact factor: 3.240

9.  Strategies for successful recombinant expression of disulfide bond-dependent proteins in Escherichia coli.

Authors:  Ario de Marco
Journal:  Microb Cell Fact       Date:  2009-05-14       Impact factor: 5.328

10.  Single-chain Fv phage display propensity exhibits strong positive correlation with overall expression levels.

Authors:  Nathan Scott; Catherine B Reynolds; Michael J Wright; Omar Qazi; Neil Fairweather; Mahendra P Deonarain
Journal:  BMC Biotechnol       Date:  2008-12-29       Impact factor: 2.563

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.